Covaxin for kids: Covid-19 vaccine trial results may be out by September, says AIIMS chief | Latest News India - Hindustan Times
close_game
close_game

Covaxin for kids: Covid-19 vaccine trial results may be out by September, says AIIMS chief

Written by Joydeep Bose | Edited by Meenakshi Ray, Hindustan Times, New Delhi
Jul 24, 2021 11:17 AM IST

In view of a probable third wave of the coronavirus pandemic, vaccination trials on children have been underway in the country. Besides Covaxin, Gujarat-based Zydus Cadila is also testing its anti-Covid shot for children.

Bharat Biotech's Covaxin Covid-19 vaccine trials for children are currently underway and its results are likely to be out by September, said Dr Randeep Guleria, the director of the All India Institute of Medical Sciences (AIIMS) in New Delhi. Last month, the AIIMS director told a Delhi-based news organisation that Covaxin shots might be available for children by September.

Dr Randeep Guleria, Director, AIIMS addresses on the third wave of Covid-19 at the National Media Centre in New Delhi. (ANI)
Dr Randeep Guleria, Director, AIIMS addresses on the third wave of Covid-19 at the National Media Centre in New Delhi. (ANI)

"The vaccines for children should come out now because trials in India are already there in the vaccines which are available in India, Bharat Biotech trial is in the final phase by September, we will have the data," news agency ANI quoted Dr Guleria as saying on Friday.

Hindustan Times - your fastest source for breaking news! Read now.

Reports said on Monday that the Hyderabad-based pharmaceutical company will administer its indigenous anti-Covid shot to children in the age group of 2-6 as part of its vaccination trials for kids.

In view of a probable third wave of the coronavirus pandemic, vaccination trials on children have been underway in the country. Besides Covaxin, Gujarat-based Zydus Cadila is also testing its anti-Covid shot for children.

Vaccine trials for kids are conducted by dividing them into different categories on the basis of their age, with 175 participants from each age group included. Once every participant has been injected with a second dose, an interim report is expected by the end of August. On the basis of this interim trial report, a decision will be taken if the vaccine is safe to be used on children.

Covaxin, along with Ahmedabad-based Zydus Cadila's three-dose shot, ZyCov-D, are the two vaccines that experts believe will be cleared for children in the near future. While Covaxin is already being used in the nationwide vaccination drive, Zydus Cadila on July 1 applied for emergency use authorisation (EUA) of its vaccine candidate for those aged 12 and above.

"Zydus Cadila vaccine has also included children and their data is already there. They have already applied for the emergency use authorisation," Guleria said.

Government officials, however, have repeatedly said that "more data" is required before an anti-Covid vaccine can be made available for children.

India has administered as many as 42.78 crore vaccines so far, as of 9am on Saturday. Of these shots, more than 40% have been provided to people in the age group of 18-44 years, 34.1% have been administered to 45-60 year-olds, and 25.4% to those above 60 years of age.

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Arvind Kejriwal News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On